Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$198.15 USD
-10.48 (-5.02%)
Updated Sep 21, 2023 04:00 PM ET
After-Market: $198.09 -0.06 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Fundamental Charts
About EPS Diluted (Quarterly)
The company's quarterly EPS Diluted value tell you how the company is doing this quarter. Diluted earnings per share offer a worst-case scenario -- what the company's stock would look like if the company had to immediately issue every share it had promised in stock options or convertible bonds. A company's diluted earnings per share is calculated by dividing the company's annual profit by its number of outstanding shares. A company with $1 million in profit and 1 million shares of outstanding stock has an EPS of $1.
CRL 198.15 -10.48(-5.02%)
Will CRL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRL
Charles River (CRL) Announces Partnership With Related Sciences
Charles River (CRL) Down 6.1% Since Last Earnings Report: Can It Rebound?
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Charles River (CRL) Stock Now
Charles River (CRL) Gains From Global Demand Amid FX Woes
Charles River (CRL) Collaborates With Fondazione Telethon
Other News for CRL
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Unveiling Charles River Laboratories International (CRL)'s Value: Is It Really Priced Right? A ...
Video: S&P 500 Movers: CRL, FDX
Charles River falls on Investor Day amid growth concerns
Charles River's updated targets below consensus expectations, says UBS